Insights On Pharmaceutical Packaging
-
Key Considerations When Developing Your Combination Product
2/20/2024
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
-
Data-Driven Methods for Ensuring Container Closure Integrity
12/18/2024
An integral component to a robust quality control program is container closure integrity testing (CCIT), which helps ensure the prevention of contamination and/or the degradation of a product.
-
Vial Containment Systems Based On Elastomer 4031/45 Gray
10/1/2024
Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.
-
The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers
8/1/2024
In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.
-
Reducing Risks By Outsourcing OSD Manufacturing And Packaging
10/23/2024
Watch to discover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.
-
Blister Solutions
3/4/2025
With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.
-
Single Unit Dose Nasal Spray Carton Provides Cost Savings
8/1/2024
Gain insight into how switching to a single-unit dose nasal sprayer carton reduced one company's material costs and significantly improved environmental sustainability throughout the product lifecycle.
-
Key Considerations When Choosing A Device For Dry Powder Nasal Delivery
10/21/2024
Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.
-
FAQs On The Revised EU GMP Annex 1: Volume 2
3/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
Delivering On GLP-1 Demand: Combining Device And Supply Strategy
5/7/2024
Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.